SEC 13F Intelligence

Managers / Q1 2019 · view latest →

Telemetry Investments, L.L.C.

CIK 0001537055 · 152 WEST 36TH STREET, ROOM 402, NEW YORK, NY, 10018-8765 · 212-425-9700

Reported Value
$197M
Q1 2019
Positions
101
Filings on Record
17
2019–present window
Filed
May 15, 2019
original filing

Summary

Telemetry Investments, L.L.C. reported $197M in U.S.-listed holdings across 101 positions for Q1 2019.

Its largest position, KDMN, represents 2.6% of the portfolio.

Compared with Q4 2018, the fund opened 37 new positions and exited 57.

Portfolio Metrics

Turnover
+40.6%
vs prior filed quarter
Top-10 Concentration
+11.4%
share of reported value
Largest Position
+2.6%
Kadmon
New / Exited
37 / 57
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $157MQ4 ’18Q1 ’19: $197MQ2 ’19: $129MQ2 ’19Q3 ’19: $35MQ4 ’19: $30MQ4 ’19Q1 ’20: $29MQ2 ’20: $37MQ2 ’20Q3 ’20: $46MQ4 ’20: $59MQ4 ’20Q1 ’21: $88MQ2 ’21: $73MQ2 ’21Q3 ’21: $74MQ4 ’21: $78MQ4 ’21Q1 ’22: $63MQ2 ’22: $84MQ2 ’22Q3 ’22: $78Mfilingsflow.com

Portfolio Composition

By security type
ETP: 49.6%Common Stock: 39.5%Other: 6.1%US DOMESTIC: 4.1%MLP: 0.3%Other: 0.3%
  • ETP · 49.6% · $98M
  • Common Stock · 39.5% · $78M
  • Other · 6.1% · $12M
  • US DOMESTIC · 4.1% · $8M
  • MLP · 0.3% · $546,000
  • Other · 0.3% · $584,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2018 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
METAFACEBOOK INCNEW+25.0K25.0K+$4M$4M
LLYLILLY ELI & CONEW+30.0K30.0K+$4M$4M
BABOEING CONEW+6.8K6.8K+$3M$3M
NOBLE ENERGY INCNEW+90.0K90.0K+$2M$2M
ELLIE MAE INCNEW+16.6K16.6K+$2M$2M
ARRIS INTERNATIONAL PLCNEW+25.0K25.0K+$790,000$790,000
MATINAS BIOPHARMA HLDGS INCNEW+650.0K650.0K+$708,000$708,000
STRONGBRIDGE BIOPHARMA PLCNEW+124.5K124.5K+$620,000$620,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

76 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1KDMNKADMON HLDGS INChistory →COM2.60%$5M1.94M
2DERMIRA INCNOTE 3.000% 5/11.68%$3M3.75M
3INTEGRATED DEVICE TECHNOLOGYCOM1.22%$2M49.1K
4XTNTXTANT MED HLDGS INChistory →COM NEW1.19%$2M768.9K
5EIGER BIOPHARMACEUTICALS INCCOM1.01%$2M142.1K
6ELLIE MAE INCCOM0.83%$2M16.6K
7AMAG PHARMACEUTICALS INCNOTE 3.250% 6/00.80%$2M1.80M
8AFFIMED N VCOM0.76%$1M355.0K
9TRCOTRIBUNE MEDIA COCL A0.67%$1M28.6K
10RED HAT INCCOM0.65%$1M7.0K
11GLDSPDR GOLD TRUSTGOLD SHS0.62%$1M10.0K
12ZOSANO PHARMA CORPCOM NEW0.59%$1M242.8K
13ACORDA THERAPEUTICS INCNOTE 1.750% 6/10.56%$1M1.25M
14NOVAVAX INCNOTE 3.750% 2/00.52%$1M2.83M
15GLOBALSTAR INCCOM · NOTE 5.750% 4/00.49%$970,0001.90M
16RETROPHIN INCCOM · NOTE 2.500% 9/10.49%$957,000521.7K
17ACRSACLARIS THERAPEUTICS INCCOM0.45%$893,000149.0K
18U S G CORPCOM NEW0.41%$816,00018.9K
19TRACON PHARMACEUTICALS INCCOM0.41%$811,000592.2K
20ARRIS INTERNATIONAL PLCSHS0.40%$790,00025.0K
21RIGEL PHARMACEUTICALS INCCOM NEW0.39%$771,000300.0K
22ROSEHILL RES INCCL A · *W EXP 09/16/2020.39%$760,000321.3K
23VRAYQVIEWRAY INCCOM0.38%$739,000100.0K
24MATINAS BIOPHARMA HLDGS INCCOM0.36%$708,000650.0K
25BABOEING COCOM0.35%$687,0001.8K
26SPRINT CORPORATIONCOM0.33%$655,000116.0K
27VERASTEM INCNOTE 5.000%11/00.33%$650,000825.0K
28STEMLINE THERAPEUTICS INCCOM0.33%$642,00050.0K
29STRONGBRIDGE BIOPHARMA PLCSHS USD0.31%$620,000124.5K
30CRVSCORVUS PHARMACEUTICALS INCCOM0.31%$604,000150.2K
31MAXWELL TECHNOLOGIES INCCOM0.30%$598,000133.8K
32OAKTREE CAP GROUP LLCUNIT CL A0.28%$546,00011.0K
33AVAAVISTA CORPCOM0.25%$496,00012.2K
34UNITED STATES NATL GAS FUNDUNIT PAR0.25%$493,00021.0K
35FNSRFINISAR CORPCOM NEW0.25%$487,00021.0K
36SPARK THERAPEUTICS INCCOM0.24%$467,0004.1K
37CICIGNA CORP NEWCOM0.20%$399,0002.5K
38INFRAREIT INCCOM0.20%$390,00018.6K
39LUXOFT HLDG INCORD SHS CL A0.18%$352,0006.0K
40ENDOLOGIX INCCOM NEW0.16%$321,00048.6K
41BMYBRISTOL MYERS SQUIBB COCOM0.15%$301,0006.3K
42ESPRESPERION THERAPEUTICS INC NECOM0.15%$301,0007.5K
43NII HLDGS INCCOM PAR0.15%$295,000150.6K
44MPCMARATHON PETE CORPCOM0.15%$287,0004.8K
45PROSHARES TR IIULTRA BLOOMBERG0.13%$265,00013.0K
46WABCO HLDGS INCCOM0.13%$264,0002.0K
47XLESELECT SECTOR SPDR TRENERGY0.13%$264,0004.0K
48MSFTMICROSOFT CORPCOM0.13%$259,0002.2K
49ADPAUTOMATIC DATA PROCESSING INCOM0.12%$240,0001.5K
50SUNESIS PHARMACEUTICALS INCCOM PAR0.12%$240,000197.6K
51SIRIUS XM HLDGS INCCOM0.12%$227,00040.0K
52COREPOINT LODGING INCCOM0.11%$217,00019.4K
53CVSCVS HEALTH CORPCOM0.11%$216,0004.0K
54NAVIGATORS GROUP INCCOM0.11%$210,0003.0K
55FITBFIFTH THIRD BANCORPCOM0.11%$207,0008.2K
56ABXBARRICK GOLD CORPORATIONCOM0.10%$206,00015.0K
57KIRKLAND LAKE GOLD LTDCOM0.10%$201,0006.6K
58SIERRA ONCOLOGY INCCOM0.10%$200,000117.1K
59CERAGON NETWORKS LTDORD0.10%$191,00053.1K
60GOLDCORP INC NEWCOM0.10%$189,00016.5K
61TRAVELPORT WORLDWIDE LTDSHS0.10%$189,00012.0K
62ADNTADIENT PLCORD SHS0.08%$159,00012.3K
63SNDXSYNDAX PHARMACEUTICALS INCCOM0.07%$131,00025.0K
64GROUPON INCCOM0.07%$129,00036.4K
65BELLEROPHON THERAPEUTICS INCCOM0.06%$126,000193.5K
66VACCINEX INCCOM0.06%$118,00022.4K
67TEUCRIUM COMMODITY TRWHEAT FD0.06%$116,00022.0K
68SCYNEXIS INCCOM0.04%$85,00056.2K
69UQM TECHNOLOGIES INCCOM0.04%$84,00051.2K
70AGIALAMOS GOLD INC NEWCOM CL A0.04%$75,00014.8K
71PACBPACIFIC BIOSCIENCES CALIF INCOM0.04%$72,00010.0K
72SENSEONICS HLDGS INCCOM0.03%$55,00022.4K
73GNWGENWORTH FINL INCCOM CL A0.03%$54,00014.0K
74CURIS INCCOM NEW0.03%$52,00026.2K
75MONEYGRAM INTL INCCOM NEW0.02%$41,00020.0K
76CAS MED SYS INCCOM PAR0.01%$27,00011.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2022Under review146Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$78M177Nov 17, 202213F-HRchanges · EDGAR ↗
Q2 2022$84M177Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$63M165May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$78M178Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$74M160Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$73M139Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$88M126May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$59M89Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$46M73Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$37M65Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$29M54May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$30M41Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$35M53Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$129M82Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$197M101May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$157M136Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.